Glucose control in type 1 diabetes: From conventional to intensive therapy

1993, The effect of intensive treatment of diabetes on the development and progression of longterm complications in insulin-dependent diabetes mellitus, NEJM, 329, 977, 10.1056/NEJM199309303291401 zinman, 1993, Insulin regimens and strategies for IDDM, Diabetes Care, 16, 24, 10.2337/diacare.16.3.24 Zinman, 1989, The physiologic replacement of insulin, NEJM, 321, 363, 10.1056/NEJM198908103210605 Home, 1997, Insulin therapy, 899 Johannesen, 1997, New insulins and other possible therapeutic approaches, Diabetologia, 40, B89, 10.1007/BF03168195 DiMarchi, 1994, Preparation of an insulin with improved pharmacokinetics relative to human insulin through consideration of structural homology with insulin-like growth factor 1, Horm Res., 41, 93, 10.1159/000183967 Holleman, 1997, Insulin Lispro, NEJM, 337, 176, 10.1056/NEJM199707173370307 Anderson, 1997, Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment, Diabetes, 46, 265, 10.2337/diabetes.46.2.265 Hollemann, 1977, Reduced frequency of severe hypoglycemia and coma in wellcontrolled IDDM patients treated with insulin Lispro, Diabetes Care, 20, 1827, 10.2337/diacare.20.12.1827 Hildebrandt, 1985, The subcutaneous absorption of human and bovine ultralente formulations, Diabet Med., 2, 355, 10.1111/j.1464-5491.1985.tb00650.x Zinman, 1997, Insulin Lispro in CSII-results of a double-blind crossover study, Diabetes, 46, 440, 10.2337/diabetes.46.3.440